Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04713228 · ClinicalTrials.gov registry record · NA

Prospective Case-Control Study of Cardiovascular Changes in Pregnancy Related Hypertensive Disorders

A NA study, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).

Terminated
Registry status
NA
Development phase
12
Enrollment target

NCT04713228 is a NA study that was terminated before completion, run by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute). The registered enrollment target is 12 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04713228, a NA study, was terminated before completion, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).

TERMINATED
Registry status
NA
Development phase
12 participants
Enrollment target

Study Summary

This is a research study to understand the changes in the heart and the cardiovascular system that may occur in women who develop high blood pressure during pregnancy.

Interventions

  • DEVICE ARTSENS Pen

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2021-07-01
Est. Completion 2024-01-17
Phase NA

What the Registry Record Tells You About NCT04713228

The ClinicalTrials.gov registry entry for NCT04713228 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), which has 34 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which ARTSENS Pen is the first listed.

NCT04713228 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04713228 about?

NCT04713228 is a clinical study titled "Prospective Case-Control Study of Cardiovascular Changes in Pregnancy Related Hypertensive Disorders". This is a research study to understand the changes in the heart and the cardiovascular system that may occur in women who develop high blood pressure during pregnancy.

What is the current status of trial NCT04713228?

This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2021-07-01. Estimated completion is 2024-01-17.

What interventions are being tested in trial NCT04713228?

The interventions under investigation include: ARTSENS Pen (DEVICE).

Who is sponsoring clinical trial NCT04713228?

This trial is sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), which has 34 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.